Interview with Simon C. W. Richardson, BSc (Hons) MSc PhD FRSB CBiol
SIMON C. W. RICHARDSON BSc (Hons) MSc PhD FRSB CBiol. Director at Intracellular Delivery Solutions Ltd., and Senior Lecturer in Biopharmaceutics, University of Greenwich, UK. How did you become interested in the field of
2016 Paper of the Year Award Winner: Victor Serebrov, PhD
Authors: William “Wes” Salomon, Samson Jolly, Victor Serebrov, Melissa Moore, Phillip Zamore – RNA Therapeutics Institute, University of Massachusetts Medical Center Presenter: Victor Serebrov, PhD RNA Therapeutics Institute, University of Massachusetts Medical Center Talk Title: Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of ...
2016 Gewirtz Memorial Scholarship Winner: Mayumi Takahashi, PhD
Mayumi Takahashi, PhD Beckman Research Institute, City of Hope Talk Title: Inhibition of HIV-1 by Gymnotically Delivered 2′-Deoxy-2′-Fluoro-D-Arabinonucleic Acid Modified Antisense Oligonucleotides (2′-FANA ASOs) Biography: Mayumi Takahashi, PhD, received B.Sc in 2005, M.Sc in 2007 and Ph.D. in 2011 under the supervision of Prof. Akira ...
Interview with Maire Fiona Osborn, PhD
Maire Fiona Osborn, Ph.D. Postdoctoral Associate, RNA Therapeutics Institute University of Massachusetts Medical School How did you become interested in the field of oligonucleotides? I took a somewhat circuitous route to the field of
2016 OTS Young Investigator Award Winner Aurélie Goyenvalle, PhD
Aurélie Goyenvalle, PhD University of Versailles Saint Quentin Talk Title: Preclinical Development of Tricyclo-DNA Antisense Oligonucleotides for the Treatment of Neuromuscular Diseases Biography: Aurélie Goyenvalle received her PhD in Virology at the University of Paris VII in 2006 from her work at Genethon in France, ...
Interview with Xianbin Yang, PhD, MBA
Xianbin Yang, PhD, MBA Director AM Biotechnologies How did you become interested in the field of oligonucleotides? I’ve been fascinated with nucleic acid chemistry and biology since my undergraduate study. I received my
Interview with Eli Gilboa, PhD
Eli Gilboa Ph.D. Dodson Professor of Microbiology & Immunology University of Miami Miller School of Medicine How did you become interested in the field of oligonucleotides? A main interest and focus of my lab is cancer immunotherapy. The overall approach has been
Interview with Maureen McKeague, PhD
Maureen McKeague, PhD, Postdoctoral Scholar, Bioengineering Department, Stanford University How did you become interested in the field? I’ve been fascinated with nucleic acids ever since high school biology. In my undergraduate degree, I enjoyed genetics
Congratulations to the Winner of the 2015 OTS Lifetime Achievement Award!
Fritz Eckstein, PhD Max Planck Institute for Experimental Medicine Dr. Eckstein received a Ph.D. in chemistry in 1960 at the University of Bonn in Germany. This was followed by a postdoctoral time at the University of Toronto for 2 years with Prof. H. Baer ...
Interview with Bart Klein
ProQR Therapeutics Property, Head of Intellectual Property How did you become interested in the field? I am a Dutch and European patent attorney with a Masters in Chemical Biology/Molecular Biology from Utrecht University, The Netherlands (Msc. 1988).
